Immediate Impact
2 hit
Citing Papers
Triple-Negative Breast Cancer: A Brief Review About Epidemiology, Risk Factors, Signaling Pathways, Treatment and Role of Artificial Intelligence
2022 Hit
Advances in studies of tyrosine kinase inhibitors and their acquired resistance
2018 Hit
Works of Ming‐Hsin Yeh being referenced
Lapatinib increases motility of triple-negative breast cancer cells by decreasing miRNA-7 and inducing Raf-1/MAPK-dependent interleukin-6
2015